小分子API(医薬品原薬)の医薬品製造受託機関 (CMO)

【英語タイトル】PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

GlobalDataが出版した調査資料(GDATA9120064)・商品コード:GDATA9120064
・発行会社(調査会社):GlobalData
・発行日:2019年8月
・ページ数:44
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:製薬及び医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,995 ⇒換算¥574,425見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD9,990 ⇒換算¥1,148,850見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD14,985 ⇒換算¥1,723,275見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

PharmSource – Contract Small Molecule API Manufacturing Industry by the Numbers – 2019 Edition
Summary

This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope

Who should buy this report?
- This 44-page report gives important, expert insight you won’t find in any other source. 26 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

- Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
-Detailed view of the geographic distribution of the small molecule API facilities
- Establishing which CMOs are most involved in contract small molecule API industry by facility count
- Analysis of M&A activity related to small molecule API facilities

【レポートの目次】

1 Table of Contents
2 List of Tables
3 List of Figures
4 Executive Summary
5 Industry Size and Structure
5.1 Definition of the Small Molecule API CMO Universe
5.2 Industry Demographics
6 Top CMOs by Small Molecule API Facilities
6.1 Controlled Substance Small Molecule API Manufacturing Facilities
6.2 Small Molecule API Manufacturing Facilities with Containment
7 Geographical Distribution of Small Molecule Manufacturing Facilities
7.1 Geographical Distribution of Controlled Substance Facilities
7.2 Geographical Distribution of Facilities with Containment Capabilities
7.3 European Analysis
8 Characteristics of the Largest CMOs
9 M&A Activity Involving Small Molecule Contract Manufacturing Facilities
10 The Outlook for the API CMO Industry
11 Notes on Methodology
12 Appendix
12.1 Appendix Tables
12.2 Bibliography
12.3 Primary Research – Key Opinion Leaders in this Report
12.4 About the Authors
12.5 Contact Us
12.6 Disclaimer

List of Tables
Table 1: Revenue Composition and Specialized Capabilities of Leading CMOs, 2018 25
Table 2: Percentage of Companies by Revenue Tier with Specialized Capabilities (Dedicated Contract and Public CMOs Only)
Table 3: CMO Small Molecule API Manufacturing Facility Acquisitions, 2015-2018 30
Table 4: CMO Small Molecule API Manufacturing Facilities Acquired by Company M&A and Divestment, 2015-2018 30
Table 5: CMO Small Molecule API Manufacturing Facilities Acquired by PE, 2015-2018 31
Table 6: Geographic Reach of CMOs with Small Molecule API Manufacturing, 2018 35
Table 7: Public CMOs’ API Manufacturing Facilities and Controlled Substance/Containment Capabilities, 2018 40

List of Figures
Figure 1: Geographic Reach of the Small Molecule API CMO Universe, 2018 (Public CMOs Only) 7
Figure 2: Public CMOs with Small Molecule Manufacturing Capability by Annual Contract Revenue, 2018 8
Figure 3: Geographic Distribution by Headquarters of Public Small Molecule API Dedicated Contract CMOs 9
Figure 4: Top CMOs by Small Molecule API Manufacturing Facilities 10
Figure 5: Top CMOs by Small Molecule API Facilities with Containment Capabilities 11
Figure 6: Top CMOs by Small Molecule API Facilities with Controlled Substance Capabilities 12
Figure 7: Oncology Pipeline by Developmental Stage and Molecule Type 14
Figure 8: Geographical Distribution of All CMO Small Molecule API Manufacturing Facilities 15
Figure 9: Geographical Distribution of Controlled Substance Small Molecule Manufacturing Facilities 17
Figure 10: Geographical Distribution of Small Molecule Manufacturing Facilities with Containment Capabilities 19
Figure 11: NMEs Requiring Special Handling, 2008-2018 20
Figure 12: Geographical Distribution of Small Molecule Contract Manufacturing Facilities in Europe, 2018 21
Figure 13: Distribution of European Small Molecule Contract Manufacturing Facilities with Containment Capabilities, 2018 22
Figure 14: Distribution of Controlled Substance European Small Molecule Contract Manufacturing Facilities, 2018 22
Figure 15: Public CMOs with Small Molecule Manufacturing Capability by Accumulated Contract Revenue, 2018 24
Figure 16: CMO Small Molecule API Manufacturing Facility with Containment Acquisitions, 2015-2018 27
Figure 17: Controlled Substance CMO Small Molecule API Manufacturing Facility Acquisitions, 2015-2018 27
Figure 18: All M&A Deals Involving Small Molecule API Containment Facilities, by Most Active CMOs, 2015-2018 28
Figure 19: All M&A Deals Involving Small Molecule API Controlled Substance Facilities, by Most Active CMOs, 2015-2018 29

【掲載企業】

Aarti Drugs Ltd
Aarti Industries Ltd
Abbott Laboratories
AbbVie Inc
Acacia Life Sciences Pvt Ltd
Aceto Corp
Advent International Corp
Agilent Technologies Inc
Ajinomoto Co Inc
Akzo Nobel NV
Albany Molecular Research Inc
Albemarle Corp
Alcami Corp
Alembic Pharmaceuticals Ltd
Alkali Metals Ltd
Alkem Laboratories Ltd
Allergan Plc
Altasciences
AMAG Pharmaceuticals Inc
Amgen Inc
AMPAC Fine Chemicals LLC
Amphastar Pharmaceuticals Inc
Antibiotice SA
Anuh Pharma Ltd
Apeloa Co Ltd
Apiscent Labs LLC
Aptuit LLC
Arc Trinova Ltd
Arch Pharmalabs Ltd
Arkema SA
Aspen Pharmacare Holdings Ltd
Astellas Pharma Inc
AstraZeneca Plc
Audax Private Equity
Auro Laboratories Ltd
Aurobindo Pharma Ltd
Avara Pharmaceutical Services Inc
Avista Pharma Solutions Inc
Bachem Holding AG
Bain Capital Private Equity, LP
Bajaj Healthcare Ltd
BASF SE
Bausch Health Companies Inc
Baxter International Inc
Bayer AG
Beximco Pharmaceuticals Ltd
BGF Investments LP
Biocon Ltd
Biotika AS
Bristol-Myers Squibb Co
C² PHARMA S.à r.l
Cadila Healthcare Ltd
Cambrex Corp
Catalent Inc
Centrient Pharmaceuticals
Changzhou Qianhong Bio-Pharma Co Ltd
Chunghwa Chemical Synthesis & Biotech Co Ltd
Church & Dwight Co Inc
Cipla Ltd
CKD Bio Corp
Companhia Industrial Produtora de Antibioticos SA
Cook Pharmica LLC
Corbion NV
CordenPharma International
Covance Inc
CVC Capital Partners Fund VI
Daewoong Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Daito Pharmaceutical Co Ltd
Dawnrays Pharmaceutical (Holdings) Ltd
Deva Holding AS
Divi's Laboratories Ltd
Dr. Reddy's Laboratories Ltd
Edgewater Capital Partners
Eisai Co Ltd
Eli Lilly and Co
Ercros SA
EstechPharma Co Ltd
Everest Organics Ltd
Everlight Chemical Industrial Corp
Evonik Industries AG
Evotec AG
F. Hoffmann-La Roche Ltd
Fareva SA
FDC Ltd
Formosa Laboratories Inc
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd
Granules India Ltd
H. Lundbeck AS
Hainan Shuangcheng Pharmaceuticals Co Ltd
Halo Pharma Inc
Hanmi Pharmaceuticals Co Ltd
High Tech Pharm Co Ltd
Hikal Ltd
Hikma Pharmaceuticals Plc
Huadong Medicine Co Ltd
IDT Australia Ltd
Inabata & Co Ltd
Indoco Remedies Ltd
Ind-Swift Laboratories Ltd
Insys Therapeutics Inc
International Isotopes Inc
IOL Chemicals and Pharmaceuticals Ltd
IPCA Laboratories Ltd
Ipsen SA
J B Chemicals and Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd
Jazz Pharmaceuticals Plc
Jeil Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Lianhuan Pharmaceutical Co Ltd
Jiangxi Fushine Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co Ltd
Johnson & Johnson
Johnson Matthey Plc
Kaneka Corp
Kemwell Biopharma Pvt Ltd
Kingchem Life Science LLC
Krebs Biochemicals & Industries Ltd
Kyowa Hakko Kirin Co Ltd
Laboratorios Farmaceuticos Rovi SA
Lannett Company Inc
Laurus Labs Ltd
LG Chem Ltd
Lianhe Chemical Technology Co Ltd
Livzon Pharmaceutical Group Co Ltd
Lonza Group Ltd
Lupin Ltd
MallInckrodt Plc
Mercachem-Syncom Group
Merck & Co Inc
Merck KGaA
Merrimack Pharmaceuticals Inc
MilliporeSigma
Minakem SAS
Mitsubishi Tanabe Pharma Corp
Morepen Laboratories Ltd
Motilal Oswal Private Equity Advisors Private Limited; Rosewood Private Investments
Mylan NV
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Nantong Jinghua Pharmaceutical Co Ltd
Natco Pharma Ltd
Nectar Lifesciences Ltd
Nektar Therapeutics
Neuland Laboratories Ltd
Nippon Fine Chemical Co Ltd
Nissan Chemical Corp
Noramco
North China Pharmaceutical Co Ltd
Northeast Pharmaceutical Group Co Ltd
Novartis AG
Novo Nordisk AS
Olon SpA
Orchid Pharma Ltd
Otsuka Holdings Co Ltd
Parabolic Drugs Ltd
Patheon NV
PCAS
Permira
Perrigo Co Plc
Pfizer Inc
PharmaCore Inc
Pharmaron Beijing Co Ltd
Piramal Enterprises Ltd
Pisgah Labs Inc
Porton Pharma Solutions Ltd
Punjab Chemicals & Crop Protection Ltd
Purdue Pharma LP
Recipharm AB
Reckitt Benckiser Group Plc
Recordati SpA
Recro Pharma Inc
Richter Gedeon Nyrt
Royal DSM NV
SAI Life Sciences Ltd
Sandoz GmbH
Sanochemia Pharmazeutika AG
Sanofi
Savior Lifetec Corp
SCI Pharmtech Inc
ScinoPharm Taiwan Ltd
SeQuent Scientific Ltd
Seven Star Pharmaceutical Co Ltd
Shandong Xinhua Pharmaceutical Co Ltd
Sharon Bio-Medicine Ltd
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Shilpa Medicare Ltd
Shionogi & Co Ltd
SI Group Inc
Siegfried Holding AG
SK Biotek Co Ltd
SK Capital Partners
Smruthi Organics Ltd
SMS Pharmaceuticals Ltd
Solara Active Pharma Sciences Ltd
Solvay SA
Sopharma AD
ST Pharm Co Ltd
Standard Chem & Pharm Co Ltd
Sterling Pharma Solutions Ltd
Strides Pharma Science Ltd
Sumitomo Chemical Co Ltd
Sun Pharmaceutical Industries Ltd
Suven Life Sciences Ltd
Syncom BV
Syngene International Ltd
Synmosa Biopharma Corp
Takeda Pharmaceutical Co Ltd
Tasmanian Alkaloids Pty Ltd
Terumo Corp
Teva Pharmaceutical Industries Ltd
The Carlyle Group
Tokuyama Corp
Torrent Pharmaceuticals Ltd
TPG Capital LP
TPI Enterprises
Tyche Industries Ltd
Ube Industries Ltd
UCB SA
Umicore NV
Unichem Laboratories Ltd
UniTao Pharmaceuticals LLC
Vistin Pharma AS
Wacker Chemie AG
Wanbury Ltd
Yakult Honsha Co Ltd
Yuki Gosei Kogyo Co Ltd
Yung Zip Chemical Ind Co Ltd
Zentiva Group as
Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Hisoar Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Jingxin Pharmaceutical Co Ltd
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Zhejiang Medicine Co Ltd
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Tianyu Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Yongtai Technology Co Ltd

★調査レポート[小分子API(医薬品原薬)の医薬品製造受託機関 (CMO)] (コード:GDATA9120064)販売に関する免責事項を必ずご確認ください。
★調査レポート[小分子API(医薬品原薬)の医薬品製造受託機関 (CMO)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆